D57.2
Sickle-cell/Hb-C disease
Clinical Classification Guidelines
Inclusion Terms
- Hb-SC disease
- Hb-S/Hb-C disease
Medical Intelligence & Overview
Sickle-cell/Hb-C disease is a genetic blood disorder that affects the shape and function of red blood cells. It is characterized by the presence of abnormal hemoglobin, which can cause red blood cells to become rigid and shaped like a crescent or sickle. These misshapen cells can block blood flow and break down prematurely, leading to various health complications. This condition is classified under ICD-10 code D57.2 and includes both sickle-cell disease and hemoglobin C disease, often occurring together.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations affecting hemoglobin production Carrying the sickle cell gene (Hb-S) or hemoglobin C gene (Hb-C) Inheritance pattern: an individual must inherit the defective gene from both parents to develop the disease Carrier status (sickle cell trait or Hemoglobin C trait) usually does not cause symptoms but can be passed to offspring
Key Symptoms: Episodes of pain (called sickle cell crises) due to blocked blood flow Fatigue and weakness caused by anemia Swelling in hands and feet Frequent infections Delayed growth and puberty in children Vision problems resulting from damage to the retina Jaundice or yellowing of the skin and eyes
Diagnostic & Treatment
Diagnosis Path: Diagnosis of sickle-cell/Hb-C disease involves blood tests such as hemoglobin electrophoresis, which identifies abnormal hemoglobin types, and complete blood counts to assess anemia. Newborn screening programs also include testing for this disease, allowing early detection and management. Additional tests may include imaging studies for organ damage and assessments of blood flow.
Treatment Protocols: While there is no universal cure for sickle-cell/Hb-C disease, several treatments can help manage symptoms and reduce complications, including: - Medications: - Pain relievers during sickle cell crises - Hydroxyurea to decrease the frequency of crises - Antibiotics and vaccines to prevent infections - Blood transfusions to reduce the proportion of sickled cells - Bone marrow transplants in certain cases - Supportive care such as hydration, oxygen therapy, and management of organ-specific issues - Regular medical follow-up to monitor health and prevent complications
Clinical Advice & FAQs
Billing Guidance
Is D57.2 a billable ICD-10 code?
Yes, D57.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.2?
Clinical documentation must specify the nature of Sickle-cell/Hb-C disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference